Exploring First-Line Treatment Strategies for Metastatic EGFR-Mutated NSCLC

Share:

Listens: 0

Project Oncology®

Science


Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Nicolas Girard, MD Dr. Charles Turck explores first-line treatment for metastatic EGFR mutated non-small cell lung cancer with pneumonologist Dr. Nicolas Girard, the head of medical oncology at the Institut Curie in Paris.